Stay connected to the latest clinical updates, teaching strategies, and practice-ready skills – delivered in a format that fits your busy life. Learn on your schedule without sacrificing quality or depth.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update Series is included with your Pharmacist Subscription. But wait…there’s even more!
What the Pharmacist CE Subscription Includes:
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
Treatment for atopic dermatitis has changed dramatically, with new therapies offering more targeted relief across the severity spectrum. This course… More Details
Advancements in hypertension management are shifting the landscape of treatment, from new guideline recommendations to technological innovations. This course explores… More Details
Alpha-gal syndrome (AGS), a growing allergy linked to tick bites and mammalian meat exposure, is a condition pharmacists can’t afford… More Details
Artificial intelligence (AI) is rapidly transforming the healthcare landscape—and pharmacy is no exception. This course explores emerging and potential uses… More Details
Second-generation (also known as atypical) antipsychotics are increasingly used as adjunctive therapy for patients with major depressive disorder who have… More Details
GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research.… More Details
Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating… More Details
As gabapentin climbs the ranks to become one of the most prescribed medications in the U.S., questions about its safety… More Details
Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures —… More Details
Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures —… More Details
Recent developments in HIV prevention — including the FDA approval of a 6‑month injectable option and updated clinical guidance —… More Details
Recent developments in HIV prevention — including the FDA approval of a 6‑month injectable option and updated clinical guidance —… More Details
